Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Express Scripts
Boehringer Ingelheim
Moodys
Baxter

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for AVENTIS PHARMACEUTI v. MYLAN PHARMACEUTICAL (D.N.J. )

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in AVENTIS PHARMACEUTI v. MYLAN PHARMACEUTICAL
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AVENTIS PHARMACEUTI v. MYLAN PHARMACEUTICAL (D.N.J. )

Date Filed Document No. Description Snippet Link To Document
2011-01-31 315 that attained by the prior art (e.g., U.S. Patent Nos. 4,254,129, 4,254,130, 4,285,957 and 4,285,958 to Carr…the patents are the “Method Patents” - United States Patent Numbers 6,03 7,3 53 (the “‘353 patent”), 6,187,791…States Patent Numbers 7,390,906 (the “‘906 patent”) and 5,750,703 (the “‘703 patent”). These patents also…the ‘703 patent. (Compare ‘703 patent, 23:45-24:6, with ‘906 patent, 22:33-58). Both patents share substantially…the ‘610 patent, which issued prior to the ‘703 patent. After the ‘610 patent issued, the Patent and Trademark External link to document
2005-06-03 68 of U.S. Patent Nos. 5,738,872 (“the ’872 patent”), 6,113,942 (“the ’942 patent”), 5,855,912 (“the ’912…’912 patent”), 5,932,247 (“the ’247 patent”), and 6,039,974 (“the ’974 patent”) which disclose solid…non-infringement of the ’942 patent, the ’912 patent, and the ’247 patent. Aventis Pharms., Inc. v. Barr…872 patent are anticipated by prior art references U.S. Patent Nos. 4,929,605 (“the ’605 patent”), 4,996,061…,061 (“the ’061 patent”), 6,037,353 (“the ’353 patent”), 5,375,693 (“the ’693 patent”), and 4,254,129 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Moodys
Johnson and Johnson
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.